One step closer to an 'exercise pill'

April 25, 2017, Experimental Biology 2017

Suppressing production of the protein myostatin enhances muscle mass and leads to significant improvements in markers of heart and kidney health, according to a study conducted in mice. Joshua T. Butcher, PhD, a postdoctoral fellow at the Vascular Biology Center at Augusta University, will present the work at the American Physiological Society's annual meeting during the Experimental Biology 2017 meeting, to be held April 22-26 in Chicago.

The researchers zeroed in on myostatin because it is known as a powerful inhibitor of skeletal muscle growth, meaning that people with more myostatin have less muscle mass and people with less myostatin have more muscle mass. Studies suggest produce more myostatin, which makes it harder to exercise and harder to build muscle mass.

"Given that exercise is one of the most effective interventions for obesity, this creates a cycle by which a person becomes trapped in obesity," Butcher said.

Obesity is linked with a range of factors that increase the risk of heart disease and diabetes, including , high cholesterol, insulin resistance and kidney damage. The researchers bred four groups of mice: lean and with uninhibited myostatin production and lean and obese mice that were unable to produce myostatin. As expected, mice that were unable to produce myostatin developed markedly higher , though the obese mice remained obese even with more muscle. The obese mice that were unable to produce myostatin showed markers of cardiovascular and metabolic health that were on par with their lean counterparts and dramatically better than obese mice with uninhibited myostatin production.

"In our muscular obese mouse, despite full presentation of obesity, it appears that several of these key pathologies are prevented," Butcher said. "While much more research is needed, at this point myostatin appears to be a very promising pathway for protection against obesity-derived cardiometabolic dysfunction.

"Ultimately, the goal of our research would be to create a pill that mimics the effect of exercise and protects against obesity. A pill that inhibits myostatin could also have applications for , such as cancer, muscle dystrophy and AIDS," he added.

Explore further: Researchers see promising results in treating age-related decline in muscle mass and power

More information: Augmented Muscle Mass as a Novel Buffer against Obesity-Derived Hypertension, app.core-apps.com/eb2017/abstr … 2834d471e29e2878b9df

Related Stories

Researchers see promising results in treating age-related decline in muscle mass and power

December 28, 2015
A proof-of-concept, phase 2 trial by an international research team has found promising results for a myostatin antibody in treating the decline in muscle mass and power associated with aging.

Possible muscle disease therapeutic target found

August 6, 2012
The study of muscular system protein myostatin has been of great interest to researchers as a potential therapeutic target for people with muscular disorders. Although much is known about how myostatin affects muscle growth, ...

Researchers solve key part of old mystery in generating muscle mass

September 27, 2012
Working with mice, Johns Hopkins researchers have solved a key part of a muscle regeneration mystery plaguing scientists for years, adding strong support to the theory that muscle mass can be built without a complete, fully ...

Fat mice bred to have more muscle give insight

August 17, 2015
Even without losing fat, more muscle appears to go a long way in fighting off the bad cardiovascular effects of obesity.

Recommended for you

New inflammation inhibitor discovered

November 16, 2018
A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able ...

Gut hormone and brown fat interact to tell the brain it's time to stop eating

November 15, 2018
Researchers from Germany and Finland have shown that so-called "brown fat" interacts with the gut hormone secretin in mice to relay nutritional signals about fullness to the brain during a meal. The study, appearing November ...

Brain, muscle cells found lurking in kidney organoids grown in lab

November 15, 2018
Scientists hoping to develop better treatments for kidney disease have turned their attention to growing clusters of kidney cells in the lab. One day, so-called organoids—grown from human stem cells—may help repair damaged ...

How the Tasmanian devil inspired researchers to create 'safe cell' therapies

November 15, 2018
A contagious facial cancer that has ravaged Tasmanian devils in southern Australia isn't the first place one would look to find the key to advancing cell therapies in humans.

Researchers discover important connection between cells in the liver

November 15, 2018
University of Minnesota Medical School researchers have made a discovery which could lead to a new way of thinking about how disease pathogenesis in the liver is regulated, which is important for understanding the condition ...

Precision neuroengineering enables reproduction of complex brain-like functions in vitro

November 14, 2018
One of the most important and surprising traits of the brain is its ability to dynamically reconfigure the connections to process and respond properly to stimuli. Researchers from Tohoku University (Sendai, Japan) and the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.